According to Viatris's latest financial reports the company's total debt is $18.37 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $18.37 B | -5.92% |
2022-12-31 | $19.52 B | -16.4% |
2021-12-31 | $23.35 B | -10.71% |
2020-12-31 | $26.16 B | 102.42% |
2019-12-31 | $12.92 B | -6.77% |
2018-12-31 | $13.86 B | -5.83% |
2017-12-31 | $14.72 B | -5.27% |
2016-12-31 | $15.53 B | 110.73% |
2015-12-31 | $7.37 B | -13.28% |
2014-12-31 | $8.50 B | 5.9% |
2013-12-31 | $8.02 B | 40.03% |
2012-12-31 | $5.73 B | 8.22% |
2011-12-31 | $5.29 B | -2.47% |
2010-12-31 | $5.43 B | 4.91% |
2009-12-31 | $5.17 B | -2.68% |
2008-12-31 | $5.32 B | -2.69% |
2007-12-31 | $5.46 B | |
2007-03-31 | $1.88 B | 173.81% |
2006-03-31 | $0.68 B | 3197.42% |
2005-03-31 | $20.91 M | 0.94% |
2004-03-31 | $20.71 M | -3.78% |
2003-03-31 | $21.52 M | -9.86% |
2002-03-31 | $23.88 M | -16.46% |
2001-03-31 | $28.59 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | -98.22% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |